Nyhetsrum - PILA PHARMA | beQuoted Nyheter

Pressmeddelanden

2026-05-19 18:00

REG

REPORT FROM PILA PHARMA AB'S ANNUAL GENERAL MEETING 2026 PILA PHARMA AB (publ) held its Annual General Meeting today, Tuesday 19 May 2026, at the company's premises at Norra Vallgatan 72 in Malmö. Attorney Krister Hjelmstedt was electe...

2026-05-06 09:30

PILA PHARMA: UPCOMING INVESTOR EVENTS AND INTERVIEWS - PRESENTING AT REDEYE DIABETES DAY ON 06 MAY PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company"), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition, today announces that it will have cor...

2026-04-21 08:50

REG

PILA PHARMA PUBLISHES ITS ANNUAL REPORT FOR 2025 PILA PHARMA AB (publ), (FN STO: PILA), ("PILA PHARMA" or the "Company"), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition, announces that its A...

2026-04-16 14:15

REG MAR

PILA PHARMA: UPDATE TO PRECLINICAL RAT OBESITY STUDIES - LOW EXPOSURE OF XEN-D0501 COULD EXPLAIN LACK OF EFFECT ON BODYWEIGHT PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company"), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition, today announces that drug exposure in...

2026-04-16 08:40

REG

KALLELSE TILL ÅRSSTÄMMA I PILA PHARMA AB Aktieägarna i PILA PHARMA AB (publ), org.nr 556966-4831, ("PILA PHARMA" eller "Bolaget") kallas härmed till årsstämma tisdagen den 19 maj 2026, kl. 15.00 i Bolagets lokaler på No...

2026-03-19 17:00

PILA PHARMA CLARIFIES: DECISION TO POSTPONE THE ANNUAL REPORT TO AWAIT CONCLUSION ON PRECLINICAL OBESITY STUDIES PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") yesterday announced that the publication of the annual report for the 2025 fiscal year and the date for the annual general...

Visa fler pressmeddelanden